Quick Answer
IONIS PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $372.26 million for the year ending 2025.
- IONIS PHARMACEUTICALS INC showed an increase of +53.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from IONIS PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2009: $215.79 million | Q3 2009: $149.29 million | Q1 2010: $98.59 million | Q2 2010: $46.04 million | Q3 2010: $100.12 million | Q1 2011: $86.20 million | Q2 2011: $85.02 million | Q3 2011: $55.26 million | Q1 2012: $56.39 million | Q2 2012: $85.65 million | Q3 2012: $84.56 million | Q1 2013: $107.65 million | Q2 2013: $296.54 million | Q3 2013: $256.41 million | Q1 2014: $161.78 million | Q2 2014: $94.08 million | Q3 2014: $73.22 million | Q1 2015: $148.35 million | Q2 2015: $119.49 million | Q3 2015: $126.59 million | Q1 2016: $93.34 million | Q2 2016: $112.53 million | Q3 2016: $84.28 million | Q1 2017: $114.22 million | Q2 2017: $132.99 million | Q3 2017: $159.18 million | Q1 2018: $227.51 million | Q2 2018: $805.49 million | Q3 2018: $479.89 million | Q1 2019: $375.81 million | Q2 2019: $272.52 million | Q3 2019: $247.94 million | Q1 2020: $486.20 million | Q2 2020: $530.18 million | Q3 2020: $633.06 million | Q1 2021: $414.16 million | Q2 2021: $565.12 million | Q3 2021: $632.95 million | Q1 2022: $542.51 million | Q2 2022: $521.92 million | Q3 2022: $314.99 million | Q1 2023: $309.03 million | Q2 2023: $424.79 million | Q3 2023: $352.06 million | Q1 2024: $348.89 million | Q2 2024: $293.99 million | Q3 2024: $334.61 million | Q1 2025: $264.19 million | Q2 2025: $297.30 million | Q3 2025: $338.34 million.
- Over the full 19 years of available data (2007 to 2025), IONIS PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 168.6%.
- Historical annual values: Fiscal year 2025: $372.26 million | Fiscal year 2024: $242.08 million | Fiscal year 2023: $399.27 million | Fiscal year 2022: $276.47 million | Fiscal year 2021: $869.19 million | Fiscal year 2020: $397.66 million | Fiscal year 2019: $683.29 million | Fiscal year 2018: $278.82 million | Fiscal year 2017: $129.63 million | Fiscal year 2016: $84.69 million | Fiscal year 2015: $128.80 million | Fiscal year 2014: $143.00 million | Fiscal year 2013: $159.97 million | Fiscal year 2012: $124.48 million | Fiscal year 2011: $65.48 million | Fiscal year 2010: $70.05 million | Fiscal year 2009: $105.26 million | Fiscal year 2008: $223.99 million | Fiscal year 2007: $138.61 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: